Pure Biologics (WAR:PUR) Total Assets : zł10.79 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Pure Biologics Total Assets?

Pure Biologics's Total Assets for the quarter that ended in Sep. 2024 was zł10.79 Mil.

During the past 12 months, Pure Biologics's average Total Assets Growth Rate was -82.60% per year. During the past 3 years, the average Total Assets Growth Rate was 24.20% per year. During the past 5 years, the average Total Assets Growth Rate was 31.90% per year.

During the past 8 years, Pure Biologics's highest 3-Year average Total Assets Growth Rate was 113.90%. The lowest was 24.20%. And the median was 53.30%.

Total Assets is connected with ROA %. Pure Biologics's annualized ROA % for the quarter that ended in Sep. 2024 was -29.43%. Total Assets is also linked to Revenue through Asset Turnover. Pure Biologics's Asset Turnover for the quarter that ended in Sep. 2024 was 0.00.

Pure Biologics Total Assets Historical Data

The historical data trend for Pure Biologics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pure Biologics Total Assets Chart

Pure Biologics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

21.09

18.94

47.19

33.01

22.74

Pure Biologics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Assets	Get a 7-Day Free Trial															65.18	22.74	19.65	11.42	10.79

Pure Biologics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Pure Biologics's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	1.893	+	20.845
	=	22.74

Pure Biologics's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2024 )	+	Total Liabilities (Q: Sep. 2024 )
	=	-4.975	+	15.765
	=	10.79

Pure Biologics (WAR:PUR) Total Assets Explanation

Total Assets is connected with ROA %.

Pure Biologics's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %	=	Net Income (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
	=	-3.268	/	( (11.421	+	10.79)	/ 2 )
	=	-3.268	/	11.1055
	=	-29.43 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Pure Biologics's Asset Turnover for the quarter that ended in Sep. 2024 is

	Asset Turnover
=	Revenue (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
=	0	/	( (11.421	+	10.79)	/ 2 )
=	0	/	11.1055
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Pure Biologics Total Assets Related Terms

Thank you for viewing the detailed overview of Pure Biologics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Pure Biologics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pure Biologics SA (WAR:PUR) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Dunska 11, Wroclaw, POL, 54-427

Website

http://www.purebiologics.pl

Pure Biologics SA is a Poland based biopharmaceutical company. It invests in the development of new, innovative (non-generic or biosimilar) biological drugs, medical and diagnostic products. It is mainly engaged in the research and development of the biologically active molecule in the drug development process. It specializes in the production and analysis of recombinant proteins and antibodies, contract studies of early product development phases, protein engineering, protein formulation, genomic sequencing, proteomics analysis and bioinformatics. Its projects include cancer immunotherapy, therapy of neurodegenerative diseases, diagnosis of tumors, and other partner projects.

Pure Biologics Headlines

No Headlines